Earnings · China A-shares
Jiangsu Cowin Biotech Co., Ltd. Class A (688426) earnings
Jiangsu Cowin Biotech Co., Ltd. Class A published its Q3 report on 2026-10-30: net profit +33.26% year on year, +30.84% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +0.85% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- +33.26%
- Excl. one-offs YoY
- +30.84%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.00% | — |
| 3 days | +0.85% | — |
| 7 days | +2.11% | — |
| 14 days | -10.24% | — |
Report history
Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 8 of 8 reports (average +3.36%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | -¥50.83M | +33.26% | +30.84% | +27.60% | -0.46 | -3.83% | +0.85% | — | — |
| 2026 interim report | 2026-08-28 | -¥35.18M | +37.07% | +31.81% | +29.73% | -0.32 | -2.63% | +0.71% | -6.25% | +3.44% |
| 2026 Q1 report | 2026-04-30 | -¥15.35M | +32.50% | +28.47% | +37.19% | -0.14 | -1.14% | +4.66% | -19.71% | -21.76% |
| 2025 annual report | 2026-04-24 | -¥107.41M | +31.68% | +22.61% | +53.74% | -0.98 | -7.63% | +2.06% | -11.62% | -12.04% |
| 2025 Q3 report | 2025-10-31 | -¥76.16M | +20.37% | +14.32% | +42.01% | -0.69 | -5.35% | +2.21% | -11.73% | -7.04% |
| 2025 interim report | 2025-08-29 | -¥55.91M | -11.70% | -8.84% | +29.74% | -0.51 | -3.90% | +3.80% | +20.15% | +18.87% |
| 2025 Q1 report | 2025-04-30 | -¥22.74M | +21.49% | +19.87% | +49.31% | -0.21 | -1.57% | +12.52% | +19.60% | +16.43% |
| 2024 annual report | 2025-04-25 | -¥157.21M | -86.25% | -51.11% | -26.54% | -1.41 | -10.05% | +0.06% | +17.57% | +14.33% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.